Morning, ladies and gentlemen. I am Henry Ji, Executive Chairperson of the Board of Scilex Holding Company. It is my pleasure to welcome you to our 2026 annual meeting. We are delighted that so many of you are able to join us today for this virtual meeting. The meeting is now called to order. I hereby appoint Stephen Ma, the company's Chief Operating Officer, Chief Financial Officer, Senior Vice President, Secretary, and a Director, to serve as the secretary of this meeting. I would also like to introduce Michael Van der Klugt of BPM, our independent registered public accounting firm. During the Q&A period at the end of today's session, Mr. Van der Klugt will be available to answer any appropriate question you may have concerning the independent audit. The Board of Directors has appointed Francis Byrd of The Carideo Group to act as the Inspector of Election for the meeting. Mr. Byrd has previously taken his oath as Inspector of Election, who will file the executed oath with the records of this meeting. Many stockholders have already submitted their proxies. All proxies will be voted as marked by the stockholder signing them. If you have voted by proxy, you do not need to take any further action. If you wish to vote during this meeting, please log in as stockholder by entering the 16-digit control number you received with your proxy materials and clicking on the Vote Here button on your screen. The secretary will now review the agenda, rules and conduct, and the procedures for today's meeting and present the Affidavit of Distribution of the Notice of Meeting. Thank you, Henry. Upon logging into the meeting, all participants were presented with an agenda and the rule of conduct and procedure for the annual meeting. To conduct an orderly meeting, we ask that participants abide by these rules. As stated in the rule of conduct, only validated stockholders may ask questions in the designated field on the web portal. Should you decide to ask questions during the meeting, please submit your question in the designated field on the portal. After the formal meeting has been adjourned, we will attempt to answer as many questions as time allows, but only questions that are relevant to the meeting or the business of the company will be addressed. Thank you for your cooperation with these rules. There are three items of business on today's agenda: the election of one Class I director, the vote on the ratification of the appointment of the company's independent registered public accounting firm, and the vote to approve an amendment to the company's 2022 Equity Incentive Plan as amended. Each of these items is described in a proxy statement filed with the SEC on April 30th, 2026. The Board of Directors set April 28, 2026, as the date of record for this stockholder meeting. A record of such stockholder as of this date has been on file at the principal place of business of the company for at least the last 10 days and has been available for inspection by any stockholder during normal business hours during that period. Mr. Chairman, I present the Affidavit of Distribution signed by Joanne Vogel of Broadridge Financial Solutions, which stated that the records relating to the meeting were mailed and deposited with the post office commencement on May 4th, 2026. Thank you, Stephen. I direct that the Affidavit of Distribution be made part of the minutes of the meeting. Our first order of business at this meeting is to determine whether the shares represented at the meetings are sufficient to constitute a quorum for the purpose of transacting business. Stephen, do you have a report? Yes. I have been advised by the Inspector of Election that as of this date, approximately 66.8% of the voting power of the issued and outstanding shares of the company's capital stock entitled to vote is represented at today's meeting, which is sufficient to constitute a quorum for the purpose of transacting business at this meeting. Thank you, Stephen. The report of the Secretary on the existence of a quorum is accepted. Since the majority of the voting power of the issued and outstanding shares of the company capital stock entitled to vote is represented here today, I declare that a quorum is present, and that the meeting is duly constituted. It is now 9:06 A.M. Pacific Time, the polls are now open for voting. If you wish to vote now, whether or not you already submitted a proxy, then you may vote using the web portal. We may now proceed to transact the business for which this meeting has been called. The next order of business is a description of matters properly brought before this meeting. The first proposal is for the election of Class I director. One director shall be elected at today's meeting to serve a three-year term until the 2029 annual meeting of stockholders, or until his respective successor is duly elected and has qualified. As indicated in the company's proxy statement, the Board of Directors has nominated and recommends a vote for Mr. Dorman Followwill, a current director of the company. Company's bylaws require that a stockholder provide advance notice to the company of a stockholder's intent to nominate a person as director. No such notice was received. Accordingly, I declare the nomination for directors closed. We will now move to Proposal two. The second proposal being submitted to stockholders for action is the ratification of appointment of BPM as our independent registered public accounting firm for the fiscal year ending December 31st, 2026. The third proposal being submitted to stockholders for action is the approval of the amendment to the 2022 Equity Incentive Plan as amended to, one, increase the number of shares authorized for issuance hereunder by 1,300,000 shares to 2,765,789 shares. And to increase the number of shares authorized for issuance thereunder pursuant to the exercise of incentive stock option to 2,765,789 shares. The company did not receive any other stockholder proposal for this year's annual meeting. Because no further business is scheduled to come before the stockholders, we will move on to voting. I now direct that a vote of the stockholders be taken on the foregoing matters. Each holder of common stock is entitled to one vote for each share of common stock, and that the holder of Series A Preferred Stock is entitled to an aggregate of 848,106 votes, both held of record at the close of business on April 28, 2026. Any stockholder who has previously given his, her, or its proxy need not vote unless he, she, or it desires to revoke the proxy and a vote by electronic ballot at this meeting. No ballots or proxies or revocation or exchange of proxy will be accepted after polls are closed. I declare the polls for each matter voted upon at this meeting closed at 9:10 A.M. Pacific Time today and direct the Inspector of Election to tabulate the ballot. Will the Secretary please report the preliminary results of the voting? Yes. Although not all the numbers of shares voted are in, I can provide the following preliminary results from the Inspector of Election. Starting with the first proposal, Mr. Followwill has been elected as Class I director. For the second proposal, ratification of the appointment of BPM to act as the company's independent registered public accounting firm for the fiscal year ending December 31st, 2026, has been approved. For the third proposal, the amendment to the 2022 Equity Incentive Plan as amended has been approved. The Inspector of Election has indicated that he will furnish me with a written report for the final vote count with respect to the matters voted on today. As final tally of the vote will be published in the current report on Form 8-K to be filed with the SEC on or before June 30th, 2026. Thank you, Stephen. Please include the Inspector of Election's written report of the final vote count in the minutes for today's meeting. There being no further business to come before the meeting, the 2026 Annual Meeting of Stockholders of Scilex Holding Company is now adjourned. We would like to answer some stockholders' question that we received today in the web portal. Please note we will attempt to answer as many questions as time allows, but only questions that are relevant to the meeting will be addressed. For questions about our commercial product or clinical program, please visit Scilex's website to view our corporate presentation and additional information. Will the Secretary please advise if we have any questions? We have no questions for purpose of relating to this meeting. This concludes our Q&A session. Thank you all for attending today's meeting and for your continuing support of Scilex Holding Company. Have a great day. This concludes today's meeting. You may now disconnect